Receptor specificity of the influenza virus hemagglutinin modulates sensitivity to soluble collectins of the innate immune system and virulence in mice

Virology

Volumn 413, Issue 1, 2011, Pages 128-138

  Tate, Michelle D ^a   Brooks, Andrew G ^a   Reading, Patrick C ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

Hemagglutinin; Influenza; Mouse; Sialic acid; Virulence

Indexed keywords

COLLECTIN; INFLUENZA VIRUS HEMAGGLUTININ; SIALIC ACID; VIRUS RECEPTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DISEASE SEVERITY; INNATE IMMUNITY; LUNG LAVAGE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RESPIRATORY EPITHELIUM; SEQUENCE ANALYSIS; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS NEUTRALIZATION; VIRUS REPLICATION;

AMINO ACID SUBSTITUTION; ANIMALS; CELL LINE; COLLECTINS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNE SYSTEM; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; LUNG; MALE; MICE; MICE, INBRED C57BL; N-ACETYLNEURAMINIC ACID; PROTEIN BINDING; RECEPTORS, VIRUS; SPECIES SPECIFICITY; VIRULENCE;

INFLUENZA A VIRUS; MURINAE; MUS; ORTHOMYXOVIRIDAE;

EID: 79953107367     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.01.035     Document Type: Article

References (91)

1. Anders E.M., Hartley C.A., Jackson D.C. Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins. Proc. Natl Acad. Sci. USA 1990, 87:4485-4489.
2. Anders E.M., Hartley C.A., Reading P.C., Ezekowitz R.A. Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. J. Gen. Virol. 1994, 75(Pt 3):615-622.
3. Baigent S.J., McCauley J.W. Glycosylation of haemagglutinin and stalk-length of neuraminidase combine to regulate the growth of avian influenza viruses in tissue culture. Virus Res. 2001, 79:177-185.
4. Briody B.A., Cassel W.A., Medill M.A. Adaptation of influenza virus to mice. III. Development of resistance to beta-inhibitor. J. Immunol. 1955, 74:41-45.
5. Brown E.G., Liu H., Kit L.C., Baird S., Nesrallah M. Pattern of mutation in the genome of influenza A virus on adaptation to increased virulence in the mouse lung: identification of functional themes. Proc. Natl Acad. Sci. USA 2001, 98:6883-6888.
6. Cheung C.Y., Poon L.L., Lau A.S., Luk W., Lau Y.L., Shortridge K.F., Gordon S., Guan Y., Peiris J.S. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease?. Lancet 2002, 360:1831-1837.
7. Chu C.M. The action of normal mouse serum on influenza virus. J. Gen. Microbiol. 1951, 5:739-757.
8. Conenello G.M., Zamarin D., Perrone L.A., Tumpey T., Palese P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 2007, 3:1414-1421.
9. Connor R.J., Kawaoka Y., Webster R.G., Paulson J.C. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 1994, 205:17-23.
10. Crouch E., Wright J.R. Surfactant proteins a and d and pulmonary host defense. Annu. Rev. Physiol. 2001, 63:521-554.
11. Deng G., Bi J., Kong F., Li X., Xu Q., Dong J., Zhang M., Zhao L., Luan Z., Lv N., Qiao J. Acute respiratory distress syndrome induced by H9N2 virus in mice. Arch. Virol. 2010, 155:187-195.
12. Doms R.W., Gething M.J., Henneberry J., White J., Helenius A. Variant influenza virus hemagglutinin that induces fusion at elevated pH. J. Virol. 1986, 57:603-613.
13. Eisen M.B., Sabesan S., Skehel J.J., Wiley D.C. Binding of the influenza A virus to cell-surface receptors: structures of five hemagglutinin-sialyloligosaccharide complexes determined by X-ray crystallography. Virology 1997, 232:19-31.
14. Eylar E.H., Madoff M.A., Brody O.V., Oncley J.L. The contribution of sialic acid to the surface charge of the erythrocyte. J. Biol. Chem. 1962, 237:1992-2000.
15. Fislova T., Gocnik M., Sladkova T., Durmanova V., Rajcani J., Vareckova E., Mucha V., Kostolansky F. Multiorgan distribution of human influenza A virus strains observed in a mouse model. Arch. Virol. 2009, 154:409-419.
16. Gabriel G., Dauber B., Wolff T., Planz O., Klenk H.D., Stech J. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc. Natl Acad. Sci. USA 2005, 102:18590-18595.
17. Gambaryan A.S., Tuzikov A.B., Piskarev V.E., Yamnikova S.S., Lvov D.K., Robertson J.S., Bovin N.V., Matrosovich M.N. Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6'-sialyl(N-acetyllactosamine). Virology 1997, 232:345-350.
18. Gambaryan A.S., Robertson J.S., Matrosovich M.N. Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses. Virology 1999, 258:232-239.
19. Gao P., Watanabe S., Ito T., Goto H., Wells K., McGregor M., Cooley A.J., Kawaoka Y. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J. Virol. 1999, 73:3184-3189.
20. Gimsa U., Grotzinger I., Gimsa J. Two evolutionary strategies of influenza viruses to escape host non-specific inhibitors: alteration of hemagglutinin or neuraminidase specificity. Virus Res. 1996, 42:127-135.
21. Glaser L., Conenello G., Paulson J., Palese P. Effective replication of human influenza viruses in mice lacking a major alpha2, 6 sialyltransferase. Virus Res. 2007, 126:9-18.
22. Hartley C.A., Jackson D.C., Anders E.M. Two distinct serum mannose-binding lectins function as beta inhibitors of influenza virus: identification of bovine serum beta inhibitor as conglutinin. J. Virol. 1992, 66:4358-4363.
23. Hartley C.A., Reading P.C., Ward A.C., Anders E.M. Changes in the hemagglutinin molecule of influenza type A (H3N2) virus associated with increased virulence for mice. Arch. Virol. 1997, 142:75-88.
24. Hatta M., Gao P., Halfmann P., Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 2001, 293:1840-1842.
25. Hawgood S., Brown C., Edmondson J., Stumbaugh A., Allen L., Goerke J., Clark H., Poulain F. Pulmonary collectins modulate strain-specific influenza a virus infection and host responses. J. Virol. 2004, 78:8565-8572.
26. Hayasaka D., Ennis F.A., Terajima M. Pathogeneses of respiratory infections with virulent and attenuated vaccinia viruses. Virol. J. 2007, 4:22.
27. Hedlund M., Tangvoranuntakul P., Takematsu H., Long J.M., Housley G.D., Kozutsumi Y., Suzuki A., Wynshaw-Boris A., Ryan A.F., Gallo R.L., Varki N., Varki A. N-glycolylneuraminic acid deficiency in mice: implications for human biology and evolution. Mol. Cell. Biol. 2007, 27:4340-4346.
28. Hensley S.E., Das S.R., Bailey A.L., Schmidt L.M., Hickman H.D., Jayaraman A., Viswanathan K., Raman R., Sasisekharan R., Bennink J.R., Yewdell J.W. Hemagglutinin receptor binding avidity drives influenza A virus antigenic drift. Science 2009, 326:734-736.
29. Herold M.J., McPherson K.G., Reichardt H.M. Glucocorticoids in T cell apoptosis and function. Cell. Mol. Life Sci. 2006, 63:60-72.
30. Hoffmann E., Krauss S., Perez D., Webby R., Webster R.G. Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 2002, 20:3165-3170.
31. Hofmann P., Sprenger H., Kaufmann A., Bender A., Hasse C., Nain M., Gemsa D. Susceptibility of mononuclear phagocytes to influenza A virus infection and possible role in the antiviral response. J. Leukoc. Biol. 1997, 61:408-414.
32. Hoffmann E., Stech J., Guan Y., Webster R.G., Perez D.R. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 2001, 146:2275-2289.
33. Ito T., Couceiro J.N., Kelm S., Baum L.G., Krauss S., Castrucci M.R., Donatelli I., Kida H., Paulson J.C., Webster R.G., Kawaoka Y. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol. 1998, 72:7367-7373.
34. Ito T., Suzuki Y., Mitnaul L., Vines A., Kida H., Kawaoka Y. Receptor specificity of influenza A viruses correlates with the agglutination of erythrocytes from different animal species. Virology 1997, 227:493-499.
35. Ito T., Suzuki Y., Takada A., Kawamoto A., Otsuki K., Masuda H., Yamada M., Suzuki T., Kida H., Kawaoka Y. Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J. Virol. 1997, 71:3357-3362.
36. Keleta L., Ibricevic A., Bovin N.V., Brody S.L., Brown E.G. Experimental evolution of human influenza virus H3 hemagglutinin in the mouse lung identifies adaptive regions in HA1 and HA2. J. Virol. 2008, 82:11599-11608.
37. Lu B., Zhou H., Ye D., Kemble G., Jin H. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics. J. Virol. 2005, 79:6763-6771.
38. Luh S.P., Chiang C.H. Acute lung injury/acute respiratory distress syndrome (ALI/ARDS): the mechanism, present strategies and future perspectives of therapies. J. Zhejiang Univ. Sci. B 2007, 8:60-69.
39. Makatsori E., Fermani K., Aletras A., Karamanos N.K., Tsegenidis T. Screening of N-acylneuraminic acids in serum and tissue specimens of mouse C57BI with Lewis' lung cancer by high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 1998, 712:23-29.
40. Markotic A., Lumen R., Marusic A., Jonjic S., Muthing J. Ganglioside expression in tissues of mice lacking the tumor necrosis factor receptor 1. Carbohydr. Res. 1999, 321:75-87.
41. Matrosovich M.N., Gambaryan A.S., Teneberg S., Piskarev V.E., Yamnikova S.S., Lvov D.K., Robertson J.S., Karlsson K.A. Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site. Virology 1997, 233:224-234.
42. Matrosovich M., Gao P., Kawaoka Y. Molecular mechanisms of serum resistance of human influenza H3N2 virus and their involvement in virus adaptation in a new host. J. Virol. 1998, 72:6373-6380.
43. Matrosovich M.N., Matrosovich T.Y., Gray T., Roberts N.A., Klenk H.D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl Acad. Sci. USA 2004, 101:4620-4624.
44. McCullers J.A., Hoffmann E., Huber V.C., Nickerson A.D. A single amino acid change in the C-terminal domain of the matrix protein M1 of influenza B virus confers mouse adaptation and virulence. Virology 2005, 336:318-326.
45. Medeiros R., Escriou N., Naffakh N., Manuguerra J.C., van der Werf S. Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes. Virology 2001, 289:74-85.
46. Medeiros R., Naffakh N., Manuguerra J.C., van der Werf S. Binding of the hemagglutinin from human or equine influenza H3 viruses to the receptor is altered by substitutions at residue 193. Arch. Virol. 2004, 149:1663-1671.
47. Ning Z.Y., Luo M.Y., Qi W.B., Yu B., Jiao P.R., Liao M. Detection of expression of influenza virus receptors in tissues of BALB/c mice by histochemistry. Vet. Res. Commun. 2009, 33:895-903.
48. Nobusawa E., Aoyama T., Kato H., Suzuki Y., Tateno Y., Nakajima K. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 1991, 182:475-485.
49. Nobusawa E., Ishihara H., Morishita T., Sato K., Nakajima K. Change in receptor-binding specificity of recent human influenza A viruses (H3N2): a single amino acid change in hemagglutinin altered its recognition of sialyloligosaccharides. Virology 2000, 278:587-596.
50. Onodera T., Taniguchi T., Tsuda T., Yoshihara K., Shimizu S., Sato M., Awaya A., Hayashi T. Thymic atrophy in type 2 reovirus infected mice: immunosuppression and effects of thymic hormone. Thymic atrophy caused by reo-2. Thymus 1991, 18:95-109.
51. Peiris J.S., Yu W.C., Leung C.W., Cheung C.Y., Ng W.F., Nicholls J.M., Ng T.K., Chan K.H., Lai S.T., Lim W.L., Yuen K.Y., Guan Y. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004, 363:617-619.
52. Pekosz A., Newby C., Bose P.S., Lutz A. Sialic acid recognition is a key determinant of influenza A virus tropism in murine trachea epithelial cell cultures. Virology 2009, 386:61-67.
53. Perrone L.A., Plowden J.K., Garcia-Sastre A., Katz J.M., Tumpey T.M. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 2008, 4:e1000115.
54. Pillai S.P., Lee C.W. Species and age related differences in the type and distribution of influenza virus receptors in different tissues of chickens, ducks and turkeys. Virol. J. 2010, 7:5.
55. Reading P.C., Morey L.S., Crouch E.C., Anders E.M. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J. Virol. 1997, 71:8204-8212.
56. Reading P.C., Miller J.L., Anders E.M. Involvement of the mannose receptor in infection of macrophages by influenza virus. J. Virol. 2000, 74:5190-5197.
57. Reading P.C., Pickett D.L., Tate M.D., Whitney P.G., Job E.R., Brooks A.G. Loss of a single N-linked glycan from the hemagglutinin of influenza virus is associated with resistance to collectins and increased virulence in mice. Respir. Res. 2009, 10:117.
58. Reading P.C., Whitney P.G., Pickett D.L., Tate M.D., Brooks A.G. Influenza viruses differ in ability to infect macrophages and to induce a local inflammatory response following intraperitoneal injection of mice. Immunol. Cell Biol. 2010, 88:641-650.
59. Rodgers B., Mims C.A. Interaction of influenza virus with mouse macrophages. Infect. Immun. 1981, 31:751-757.
60. Rogers G.N., Paulson J.C. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 1983, 127:361-373.
61. Russell R.J., Stevens D.J., Haire L.F., Gamblin S.J., Skehel J.J. Avian and human receptor binding by hemagglutinins of influenza A viruses. Glycoconj. J. 2006, 23:85-92.
62. Ryan L.K., Neldon D.L., Bishop L.R., Gilmour M.I., Daniels M.J., Sailstad D.M., Selgrade M.J. Exposure to ultraviolet radiation enhances mortality and pathology associated with influenza virus infection in mice. Photochem. Photobiol. 2000, 72:497-507.
63. Ryan-Poirier K.A., Kawaoka Y. Distinct glycoprotein inhibitors of influenza A virus in different animal sera. J. Virol. 1991, 65:389-395.
64. Ryan-Poirier K.A., Kawaoka Y. Alpha 2-macroglobulin is the major neutralizing inhibitor of influenza A virus in pig serum. Virology 1993, 193:974-976.
65. Sauter N.K., Hanson J.E., Glick G.D., Brown J.H., Crowther R.L., Park S.J., Skehel J.J., Wiley D.C. Binding of influenza virus hemagglutinin to analogs of its cell-surface receptor, sialic acid: analysis by proton nuclear magnetic resonance spectroscopy and X-ray crystallography. Biochemistry 1992, 31:9609-9621.
66. Shilov A.A., Sinitsyn B.V. Changes in its hemagglutinin during the adaptation of the influenza virus to mice and their role in the acquisition of virulent properties and resistance to serum inhibitors. Vopr. Virusol. 1994, 39:153-157.
67. Skehel J.J., Wiley D.C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 2000, 69:531-569.
68. Smeenk C.A., Wright K.E., Burns B.F., Thaker A.J., Brown E.G. Mutations in the hemagglutinin and matrix genes of a virulent influenza virus variant, A/FM/1/47-MA, control different stages in pathogenesis. Virus Res. 1996, 44:79-95.
69. Stoner G.D., Kikkawa Y., Kniazeff A.J., Miyai K., Wagner R.M. Clonal isolation of epithelial cells from mouse lung adenoma. Cancer Res. 1975, 35:2177-2185.
70. Sur S., Wild J.S., Choudhury B.K., Sur N., Alam R., Klinman D.M. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. J. Immunol. 1999, 162:6284-6293.
71. Suzuki Y., Matsunaga M., Matsumoto M. N-Acetylneuraminyllactosylceramide, GM3-NeuAc, a new influenza A virus receptor which mediates the adsorption-fusion process of viral infection. Binding specificity of influenza virus A/Aichi/2/68 (H3N2) to membrane-associated GM3 with different molecular species of sialic acid. J. Biol. Chem. 1985, 260:1362-1365.
72. Suzuki Y., Nagao Y., Kato H., Matsumoto M., Nerome K., Nakajima K., Nobusawa E. Human influenza A virus hemagglutinin distinguishes sialyloligosaccharides in membrane-associated gangliosides as its receptor which mediates the adsorption and fusion processes of virus infection. Specificity for oligosaccharides and sialic acids and the sequence to which sialic acid is attached. J. Biol. Chem. 1986, 261:17057-17061.
73. Suzuki T., Takahashi T., Guo C.T., Hidari K.I., Miyamoto D., Goto H., Kawaoka Y., Suzuki Y. Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication. J. Virol. 2005, 79:11705-11715.
74. Sweet C., Smith H. Pathogenicity of influenza virus. Microbiol. Rev. 1980, 44:303-330.
75. Tate M.D., Brooks A.G., Reading P.C. The role of neutrophils in the upper and lower respiratory tract during influenza virus infection of mice. Respir. Res. 2008, 9:57.
76. Tate M.D., Deng Y.M., Jones J.E., Anderson G.P., Brooks A.G., Reading P.C. Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J. Immunol. 2009, 183:7441-7450.
77. Tate, M.D., Brooks, A.G., Reading, P.C., 2010a. Inhibition of lectin-mediated innate host defences in vivo modulates disease severity during influenza virus infection. Immunol Cell Bio. In press.
78. Tate M.D., Pickett D.L., van Rooijen N., Brooks A.G., Reading P.C. Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J. Virol. 2010, 84:7569-7580.
79. Tate M.D., Brooks A.G., Reading P.C. Correlation between sialic acid expression and infection of murine macrophages by different strains of influenza virus. Microb. Infect. 2011, 13:202-207.
80. Tumpey T.M., Garcia-Sastre A., Taubenberger J.K., Palese P., Swayne D.E., Pantin-Jackwood M.J., Schultz-Cherry S., Solorzano A., Van Rooijen N., Katz J.M., Basler C.F. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol. 2005, 79:14933-14944.
81. Tumpey T.M., Lu X., Morken T., Zaki S.R., Katz J.M. Depletion of lymphocytes and diminished cytokine production in mice infected with a highly virulent influenza A (H5N1) virus isolated from humans. J. Virol. 2000, 74:6105-6116.
82. Vigerust D.J., Ulett K.B., Boyd K.L., Madsen J., Hawgood S., McCullers J.A. N-linked glycosylation attenuates H3N2 influenza viruses. J. Virol. 2007, 81:8593-8600.
83. Vines A., Wells K., Matrosovich M., Castrucci M.R., Ito T., Kawaoka Y. The role of influenza A virus hemagglutinin residues 226 and 228 in receptor specificity and host range restriction. J. Virol. 1998, 72:7626-7631.
84. Wagner R., Matrosovich M., Klenk H.D. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev. Med. Virol. 2002, 12:159-166.
85. Weis W., Brown J.H., Cusack S., Paulson J.C., Skehel J.J., Wiley D.C. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 1988, 333:426-431.
86. Wells M.A., Albrecht P., Daniel S., Ennis F.A. Host defense mechanisms against influenza virus: interaction of influenza virus with murine macrophages in vitro. Infect. Immun. 1978, 22:758-762.
87. Whitehead G.S., Burch L.H., Berman K.G., Piantadosi C.A., Schwartz D.A. Genetic basis of murine responses to hyperoxia-induced lung injury. Immunogenetics 2006, 58:793-804.
88. Widjaja L., Ilyushina N., Webster R.G., Webby R.J. Molecular changes associated with adaptation of human influenza A virus in embryonated chicken eggs. Virology 2006, 350:137-145.
89. Wyde P.R., Couch R.B., Mackler B.F., Cate T.R., Levy B.M. Effects of low- and high-passage influenza virus infection in normal and nude mice. Infect. Immun. 1977, 15:221-229.
90. Xing Z., Kirpalani H., Torry D., Jordana M., Gauldie J. Polymorphonuclear leukocytes as a significant source of tumor necrosis factor-alpha in endotoxin-challenged lung tissue. Am. J. Pathol. 1993, 143:1009-1015.
91. Xu T., Qiao J., Zhao L., Wang G., He G., Li K., Tian Y., Gao M., Wang J., Wang H., Dong C. Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice. Am. J. Respir. Crit. Care Med. 2006, 174:1011-1017.